Dimethylformamide

Dimethylformamide

SCHEMBL4622671

CN(C)C=O.CN(CCOc1ccc(C#N)cc1)c1ccccn1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
MAPT P10636 5/20 0.54
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 2/20 0.54
PKM P14618 2/20 0.54
HTT P42858 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
PPARG P37231 7/20 0.53
RARG P13631 1/20 0.49
RXRA P19793 1/20 0.49
MMP2 P08253 3/20 0.49
MMP3 P08254 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 2/20 0.46
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP1A2 P05177 1/20 0.45
GAA P10253 1/20 0.45
GBA1 P04062 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4622907 0.93 KMT2A (0.57) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL1201631 0.81 MAPT (0.66) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL7920967 0.78 KMT2A (0.60) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL7160716 0.77 MAPT (0.63) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL7160719 0.77 MAPT (0.63) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL3117237 0.77 KMT2A (0.59) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL3117214 0.77 KMT2A (0.59) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL5374848 0.75 PPARG (0.61) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL7914462 0.75 PPARG (0.58) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL5381839 0.75 PPARG (0.58) KMT2AMAPTALDH1A1KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1905761-A1 An improved process for the preparation of 4-[2-(methyl-2-pyridinylamino) ethoxy] benzaldehyde, an intermediate for the preparation of rosiglitazone Cadila Pharmaceuticals Limited (IN) 2008-04-02 EP disclosed